Cardiac and vascular morbidity in women receiving adjuvant tamoxifen for breast cancer in a randomised trial-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Cardiac and vascular morbidity in women receiving adjuvant tamoxifen for breast cancer in a randomised trial

Published:1995-10-14 Issue:7011 Volume:311 Page:977-980
ISSN:0959-8138
Container-title:BMJ
language:en
Short-container-title:BMJ

Author:

McDonald C. C,Alexander F. E,Whyte B. W,Forrest A P.,Stewart H. J

Publisher

BMJ

Subject

General Earth and Planetary Sciences,General Environmental Science,General Engineering

Cited by 206 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The beneficial effects of tamoxifen on arteries: A key player for cardiovascular health of breast cancer patient;Biochemical Pharmacology;2023-08

2. Maladie thromboembolique veineuse et cancer du sein;Bulletin du Cancer;2023-07

3. The Cardiovascular Risks Associated with Aromatase Inhibitors, Tamoxifen, and GnRH Agonists in Women with Breast Cancer;Current Atherosclerosis Reports;2023-02-27

4. Incidence of Venous Thromboembolism Based on Caprini Score in Deep Inferior Epigastric Perforator Flap Breast Reconstruction;Journal of Reconstructive Microsurgery;2023-02-21

5. Incident comorbidities after tamoxifen or aromatase inhibitor therapy in a racially and ethnically diverse cohort of women with breast cancer;Breast Cancer Research and Treatment;2022-08-28

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP